Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05001516
Title Study of Turning Point Therapeutics LM-302 in Patients With Advance Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Turning Point Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Local Institution - 0013 Duarte California 91010 United States Details
Local Institution - 0017 Fullerton California 92835 United States Details
Local Institution - 0012 Lafayette Indiana 47905 United States Details
Local Institution - 0020 Paramus New Jersey 07652 United States Details
Local Institution - 0018 New York New York 10016 United States Details
Local Institution - 0016 Oklahoma City Oklahoma 73120 United States Details
Local Institution - 0015 Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field